Free Trial
NYSE:IH

iHuman (IH) Stock Price, News & Analysis

iHuman logo
$1.75 -0.02 (-0.89%)
(As of 05:12 PM ET)

About iHuman Stock (NYSE:IH)

Key Stats

Today's Range
$1.73
$1.78
50-Day Range
$1.52
$1.98
52-Week Range
$1.47
$3.18
Volume
4,964 shs
Average Volume
28,092 shs
Market Capitalization
$91.87 million
P/E Ratio
5.16
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

iHuman Inc. provides intellectual development products to individual users, kindergartens, and distributors in the People's Republic of China. The company offers interactive and self-directed learning apps, including iHuman Chinese, iHuman ABC, iHuman Pinyin, iHuman Magic Thinking, iHuman Books, iHuman Stories, iHuman Reading, iHumanpedia, iHuman Kids Workout, iHuman Coding, iHuman Fun Idioms, iHuman Little Artists, iHuman Writing, iHuman Fantastic Friends, and iHuman Readers; bekids Coding, bekids Coloring, bekids Reading, bekids Puzzle, bekids Academy, and Gogo Town; and Aha World, an open-ended interactive app that nurtures a desire for discovery. It provides intellectually stimulating materials, including books, interactive materials, and smart devices that develop children's abilities in speaking, critical thinking, independent reading, and creativity. iHuman Inc. was founded in 1996 and is based in Beijing, the People's Republic of China.

iHuman Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
52nd Percentile Overall Score

IH MarketRank™: 

iHuman scored higher than 52% of companies evaluated by MarketBeat, and ranked 168th out of 288 stocks in the consumer discretionary sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for iHuman.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of iHuman is 5.16, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 134.78.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of iHuman is 5.16, which means that it is trading at a less expensive P/E ratio than the Consumer Discretionary sector average P/E ratio of about 18.27.

  • Price to Book Value per Share Ratio

    iHuman has a P/B Ratio of 0.69. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    0.01% of the outstanding shares of iHuman have been sold short.
  • Short Interest Ratio / Days to Cover

    iHuman has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in iHuman has recently decreased by 39.34%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    iHuman does not currently pay a dividend.

  • Dividend Growth

    iHuman does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.01% of the outstanding shares of iHuman have been sold short.
  • Short Interest Ratio / Days to Cover

    iHuman has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in iHuman has recently decreased by 39.34%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    iHuman has a news sentiment score of 0.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.67 average news sentiment score of Consumer Discretionary companies.
  • Search Interest

    8 people have searched for IH on MarketBeat in the last 30 days.
  • MarketBeat Follows

    1 people have added iHuman to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, iHuman insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    63.60% of the stock of iHuman is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 4.92% of the stock of iHuman is held by institutions.

  • Read more about iHuman's insider trading history.
Receive IH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iHuman and its competitors with MarketBeat's FREE daily newsletter.

IH Stock News Headlines

Returns At iHuman (NYSE:IH) Are On The Way Up
iHuman Inc. (IH)
Uncover the Top Gold Stock of the Bull Market
Gold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?
That obscure object of desire
See More Headlines

IH Stock Analysis - Frequently Asked Questions

iHuman's stock was trading at $3.07 at the beginning of the year. Since then, IH shares have decreased by 42.9% and is now trading at $1.7542.
View the best growth stocks for 2024 here
.

iHuman Inc. (NYSE:IH) released its quarterly earnings results on Friday, September, 27th. The company reported $0.06 EPS for the quarter. The company had revenue of $29.60 million for the quarter. iHuman had a trailing twelve-month return on equity of 14.17% and a net margin of 13.72%.

iHuman (IH) raised $84 million in an initial public offering on Friday, October 9th 2020. The company issued 7,000,000 shares at a price of $11.00-$13.00 per share. Credit Suisse and Citigroup acted as the underwriters for the IPO and Tiger Brokers, CMBI and CLSA were co-managers.

Shares of IH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that iHuman investors own include Chevron (CVX), Baidu (BIDU), Tencent Music Entertainment Group (TME), Alibaba Group (BABA), Exxon Mobil (XOM), Abbott Laboratories (ABT) and JD.com (JD).

Company Calendar

Last Earnings
9/27/2024
Today
12/18/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Educational services
Sub-Industry
N/A
Fax
N/A
Employees
783
Year Founded
N/A

Profitability

Net Income
$25.48 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$962.05 million
Cash Flow
$0.52 per share
Book Value
$2.56 per share

Miscellaneous

Free Float
19,063,000
Market Cap
$90.71 million
Optionable
Not Optionable
Beta
0.45
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

This page (NYSE:IH) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners